Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004458 |
---|---|
Receipt number | R000005337 |
Scientific Title | Phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node positive early stage breast cancer |
Date of disclosure of the study information | 2010/11/01 |
Last modified on | 2021/11/11 17:17:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/10/27 14:19:07 | ||
2 | Update | 2012/05/02 10:44:38 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2012/09/12 15:52:33 | Recruitment status |
|
4 | Update | 2013/10/29 13:21:38 | Email Institutions |
|
5 | Update | 2013/10/29 13:36:00 | Institutions |
|
6 | Update | 2014/10/30 13:55:36 | Address Address TEL Address Address TEL |
|
7 | Update | 2014/10/30 13:59:17 | Key inclusion criteria |
|
8 | Update | 2016/05/09 09:17:57 | Name of primary person or sponsor Organization |
|
9 | Update | 2018/08/17 10:29:22 | Acronym Acronym |
|
10 | Update | 2018/08/23 17:39:21 | Public title |
|
11 | Update | 2018/08/24 10:05:09 | UMIN ID1 |
|
12 | Update | 2020/05/14 15:23:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Organization Organization Address Address Tel |
|
13 | Update | 2021/08/24 14:49:40 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
14 | Update | 2021/08/24 15:36:52 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
15 | Update | 2021/08/26 15:18:25 | Recruitment status |
|
16 | Update | 2021/08/27 13:25:34 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
17 | Update | 2021/11/11 17:17:06 | Results Baseline Characteristics Participant flow Adverse events Outcome measures |